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Abstract. Aim: The biopotential of the essential oils of the Greek aromatic plants 
Satureja thymbra and Satureja parnassica were investigated, together with their major 
components carvacrol, thymol, γ-terpinene and p-cymene. Materials and Methods: 
Antioxidant and cancer cell cytotoxic properties were determined using 2,2-diphenyl-
1-picrylhydrazyl and sulforhodamine B assays, respectively.  The antiproliferative 
potential was studied against the cell lines, MCF-7, A549, HepG2 and Hep3B. Results: 
S. thymbra  oil possessed stronger antioxidant and antiproliferative capacity when 
tested on MCF-7 cells compared to S. parnassica oil. Thymol exhibited two-fold 
greater antioxidant potency than carvacrol, whereas γ-terpinene and  p-cymene had  
no significant effect. Carvacrol was the most potent antiproliferative agent against 
A549 cells, while Hep3B cells were the most sensitive to thymol. p-Cymene and γ-
terpinene demonstrated negligible bioactivity. Conclusion: S. thymbra and S. 
parnassica essential oils exhibit significant but diverse antioxidant and antiproliferative 
activities, mainly attributed to their main components, carvacrol and thymol. 
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Aromatic plants have been used for their preservative and medicinal properties since 
ancient times. These properties are attributed to some extent to essential oils, which 
are formed as secondary metabolites. The term 'essential oils' was first used five 
centuries ago by Paracelsus von Hohenheim, who named the active constituent of a 
drug ‘Quinta essential’ (1). Essential oils are extracted from plants mainly by 
distillation. They contain mostly terpenes and some other non-terpene components.  
Their physical role is to protect plants against bacteria, fungi, viruses, insects and 
even against herbivores, whose appetite they reduce for these plants (2). They have 
been used against microorganisms, as sedatives, for food preservation, and as food 
additives for aroma in cosmetics and perfumes (1, 2). Although their therapeutic 
potential had been put aside for decades, it has drawn increasing attention from the 
scientific community since the 1950s. This coincides with a general public trend 
away from chemical substances and towards using natural products for the 
treatment of many diseases. As a result, many scientific groups are investigating the 
antioxidant, antimicrobial, antifungal, antiviral, anticancer and other properties of 
essential oils and their main constituents.   
  Satureja thymbra (common names: thyme-leaved savory, pink savory, thrubi) 
is an aromatic plant endemic to the Mediterranean region and is the most common 
specimen of the Satureja genus. The essential oil obtained from the S. thymbra plant 
has been tested against several organisms and showed to possess potent antioxidant, 
antifungal, antibacterial, antiviral and insecticidal properties (3- 8). It has also been 
studied for its cytotoxic potential against human cancer cell lines (9). S. parnassica is 
endemic to central and southern Greece. The biological activities of S. parnassica 
have been studied to a lesser extent; however, the existing studies reveal it to have a 
potent antibacterial and insecticidal essential oil (3-5). Both plants have been used 
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since ancient times as local spices and herbal home remedies, due to their antiseptic 
and diuretic properties. The composition of their essential oils depends on the 
harvesting time (e.g. before or after flowering).  However, it has been shown that two 
phenol monoterpenes, carvacrol and thymol, are the major components at all 
harvesting times. Moreover, thymol and carvacrol, together with their biosynthetic 
precursors, p-cymene and γ-terpinene, comprise more than 70% of the oil (3, 4).  
 The composition of an essential oil may play an important role in its biological 
activities. Therefore, the major constituents of the essential oils of S. thymbra and S. 
parnassica, carvacrol and thymol, have also been studied for their potential protective 
and therapeutic role against a wide variety of pathological conditions and organisms 
(1, 2, 10). In moderate concentrations, they do not affect the viability of normal cells 
and have been shown to protect cells from oxidative stress induced by agents such 
as H2O2 (11- 13). Their promising activities, together with the low toxicity they present, 
may allow for their use as the basis for drug development, alone or together with 
known synthetic drugs in order to enhance their efficacy. 
 The aim of this study was to determine the antioxidant and potential 
antiproliferative activity of the Greek S. thymbra and S. parnassica essential oils. In 
addition, we wanted to examine the biological potency of their main components in 
vitro; therefore the antioxidant and antiproliferative properties of carvacrol, thymol, p-
cymene and γ-terpinene against a panel of human cancer cell lines were also 
investigated.   
 
Materials and Methods 
Chemicals and reagents. Dulbecco's modified eagle's medium (DMEM), fetal bovine 
serum (FBS), trypsin, and penicillin/streptomycin were purchased from Biochrom AG, 
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F12K medium was obtained from Gibco (Gaithersburg, MD, USA). Phosphate-
buffered saline (PBS) was purchased from Biosera (Boussens, France).  Ascorbic 
acid, dimethyl sulfoxide (DMSO), sulforhodamine B (SRB), Trizma base, carvacrol, 
thymol, p-cymene and γ-terpinene were purchased from Sigma-Aldrich (St Louis, MO, 
USA). Trichloroacetic acid (TCA) was purchased was from Applichem (Darmstadt, 
Germany), acetic acid  from Scharlau (Barcelona, Spain), and 2,2-diphenyl-1-
picrylhydrazyl (DPPH) was purchased from Calbiochem (Darmstadt,  Germany).  
 
Essential oils. Essential oils of S. thymbra and S. parnassica originated from plants 
that were harvested after their flowering season and were extracted as described in 
the study by Chorianopoulos et al. (4). The main components of the oils is presented 
in Table I.  
 
Cell lines and cell cultures. The human cancer cell lines MCF-7 (mammary 
adenocarcinoma, A549 (non-small cell lung adenocarcinoma), HepG2 and Hep3Β 
(hepatocellular carcinomas) were obtained from the American Type Culture Collection 
(Rockville, MD, USA). HepG2, Hep3B, and MCF-7 cells were grown and maintained 
in DMEM, whereas the F12K medium was used for the A549 cell line. All media were 
supplemented with 10% FBS, penicillin (100 U/ml) and streptomycin (100 μg/ml) and 
were incubated at 37°C in a humidified atmosphere of 95% O2 and 5% CO2. Stock 
cultures were passaged at 2- to 3-day intervals. Cells were seeded at a density of 
5.0×103cells per well in 96-well plates for the SRB assay. 
 
Antioxidant activity (DPPH assay). The radical-scavenging activity of the essential oils 
and their major components was estimated using the free radical DPPH. Increasing 
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concentrations of the oils [S. parnassica 2-100% (v/v) and S. thymbra 0.4-100%(v/v)]  
and their major components (0.1-10 mM) were prepared using DMSO as a solvent. 
Using a final volume of 10 μl, each concentration was placed in a 96-well plate in 
triplicates then 190 μl of an 800 μΜ methanolic solution of DPPH were added.  Ten 
microliters of DMSO with 190 μl DPPH were used as a control. The plate was left in 
the dark for 30 min, and then the absorbance was measured at 517 nm using an ELISA 
plate reader (Sunrise, Tecan, Männedorf,  Switzerland). Ascorbic acid at 
concentrations of 10-640 μΜ was used as a standard as it is a known potent 
antioxidant.  
     The percentage inhibition of the DPPH radical for each concentration was 
determined according to the following formula: 
DPPH radical-scavenging activity (%) = [(ODcontrol − ODsample)÷ODcontrol]×100 
 
SRB assay. The viability of human cancer cells after treatment with essential oils and 
their components was determined using the SRB assay. SRB is a dye that binds to 
basic amino acids of cellular proteins, and the number of viable cells is then estimated 
with colorimetric evaluation. Cells were plated in 96-well plates and treated with 
different concentrations of each of the test substances for 72 h. The concentrations 
were 0.00000025-0.25% (v/v) for the oils, 1-10 mM for p-cymene and γ-terpinene for 
the MCF-7 cell line, and 1-1000 μΜ for carvacrol and thymol for the remaining cancer 
cell lines. After treatment, cells were fixed with the addition of 25 μl of 50% (w/v) cold 
TCA to the growth medium and the plates were incubated at 4°C for 1 h. The cells 
were washed five times with tap water and then stained with 50 μl of 0.4% (w/v) SRB 
in 1% (v/v) acetic acid for 30 min at room temperature. Five rinses with 1% (v/v) acetic 
acid followed to remove unbound dye. The fixed, stained plates were allowed to air-
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dry and  the bound dye was then solubilized by adding 100 μl of 10 mM Trizma base 
for at least 5 min. Absorbance was measured at 570 nm using an ELISA plate reader 
and the percentage cellular survival was calculated using the formula:  
[(ODSample − ODmedium blank)÷(mean ODcontrol − ODmedium blank)]×100 
 
Data analysis. All experiments were performed at least in triplicate. The  concentration 
of test sample required to cause a 50% reduction in the DPPH free radical (IC50) and  
required to reduce cancer cell viability by 50% (EC50) were calculated from the 
respective dose–response curves by regression analysis using a four-parameter 
logistic curve through Sigma Plot Software (v.10) (Systat Software Inc., San Jose, 
California, USA). 
 
Results  
Antioxidant activity. DPPH assay is widely used for the evaluation of the properties of 
various plant constituents for scavenging free radicals (14). The results show that S. 
thymbra oil exhibited stronger antioxidant capacity [IC50=0.22±0.25% (v/v)] compared 
with S. parnassica essential oil [IC50=0.4±0.3% (v/v)]. The scavenging activity of the 
oils is presented in Figure 1. The IC50 value for ascorbic acid was estimated to be 
0.032±0.0034 mΜ (data not shown), similar to a previous report (15). The IC50 values 
for carvacrol and  thymol were estimated to be 2.28±0.45 mM and 1.14±0.18 mM, 
respectively (Figure 2). Thymol is a stronger antioxidant, exhibiting 35 times lower 
activity than ascorbic acid. Carvacrol, on the other hand, was found to have 70 times 
less scavenging activity than ascorbic acid. On the other hand, γ-terpinene and p-
cymene did not show any significant scavenging activity in the range of concentrations 
tested (Table II).  
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Antiproliferative activity. The antiproliferative potential of the essential oils of the 
selected plants and their components was tested using the SRB cell viability assay. 
Essential oils of the plants S. thymbra and S. parnassica were tested for their 
anticancer potential against mammary adenocarcinoma MCF-7 cells. S. thymbra oil 
exhibited higher cytotoxicity [EC50=0.002±0.00038% (v/v)] than S. parnassica oil 
[EC50= 0.08±0.03% (v/v)] after incubation with cells for 72 h (Figure 3).  
 The antiproliferative potential of γ-terpinene and p-cymene was also tested 
against the MCF-7 cancer cell line. The viability of cancer cells was not significantly 
affected (EC50 values were 4.6±0.11 mM and 5.11±0.5 5mM for γ-terpinene and p-
cymene, respectively) and, therefore, they were not further tested (Table III).  
 Carvacrol and thymol, on the other hand, exhibited noteworthy cytotoxicity and 
were examined against the A549, Hep3B and HepG2 cancer cell lines (Figure 4, Table 
III). Carvacrol had the most potent cytotoxicity against A549 cells (EC50=0.118±0.0012 
mΜ). Hep3B cells were found to be more resistant (EC50=0.234±0.017 mΜ), while 
HepG2 cells were the least sensitive to treatment with carvacrol (EC50=0.344±0.0035 
mΜ).  
 Thymol, on the other hand, was most effective against Hep3B cells 
(EC50=0.181±0.016 mΜ). A549 cells were less sensitive to thymol (EC50=0.187±0.061 
mΜ), similar to treatment with carvacrol. HepG2 cells were once again the most 
resistant, with an EC50 value greater than 0.35 mΜ (EC50=0.390±0.01 mΜ). 
 
Discussion 
Antioxidant activity. The essential oil of S. thymbra was found to possess 
approximately two-fold stronger antioxidant capacity than the oil of S. parnassica using 
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the DPPH-scavenging method. This may be due to the fact that the oil of S. parnassica 
contains a higher percentage of γ-terpinene and p-cymene, which we showed to 
possess no antioxidant activity.  To our knowledge, this is the first time that the 
antioxidant capacity of S. parnassica has been determined. The essential oil of S. 
thymbra, on the other hand, showed strong antioxidant activity in a study where the oil 
was derived from plants collected during their flowering stage in Libya (8).  
 In our study, thymol had the strongest antioxidant activity among the other 
components of theseessential oils (IC50=1.14±0.18 mM), at a value that was 35 times 
lower than that of ascorbic acid. Carvacrol was found to possess two-fold lower activity 
compared to thymol and 70-fold lower compared to ascorbic acid (IC50=2.28±0.45 mM) 
whereas p-cymene and γ-terpinene did not exhibit any antioxidant capacity in vitro. 
These results are in agreement with a study in 2012 where carvacrol and thymol were 
found to be the most potent antioxidants using the 2,2'-azino-bis-3-
ethylbenzothiazoline-6-sulphonic acid method; however, the IC50 values for the 
terpenes were significantly lower (16). 
 Carvacrol and thymol are considered strong antioxidant agents, and this is 
proven by studies that deal not only with the isolated phenols but also with oils that 
contain these compounds at a high percentage. In a study of 2012, for example, the 
essential oils of seven Thymus species were divided according to their content and 
tested for their antioxidant capacity. The group of oils that contained carvacrol as their 
main component demonstrated the highest activity (17). Carvacrol has also shown 
strong antioxidant capacity using different in vitro methods (18). In addition, both 
phenols have been examined individually for their properties, showing significant 
antioxidant properties in vitro (19).
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 Carvacrol and thymol were the components considered responsible for the 
antioxidant activity of the essential oil of Thymus pectinatus, Ocimum basilicum L. 
Origanum vulgare L. and Thymus vulgaris L ( 20, 21). Finally, in a study where different 
extracts and essential oil chemotypes of Thymus vulgaris were screened, the highest 
activity was shown by the oils that were abundant in thymol (22).  
 p-Cymene has demonstrated only weak antioxidant activity whenever it has 
been studied and regardless of the assay used (19, 23, 24). γ-Τerpinene, on the other 
hand, was found to possess strong antioxidant capacity using the DPPH method (23). 
Similarly, in another study, γ-terpinene had significant antioxidant activity, comparable 
with that of α-tocopherol, a known antioxidant (19). Conversely, more recently it was 
considered to possess moderate antioxidant capacity, but the concentrations that were 
used in that study were quite high (0-180 mM) (25). Finally, its IC50 value was found 
to be 30 mM using the DPPH assay after an incubation period of 26 h (26).  
 
Antiproliferative activity. This is the first time as far as we are aware that the 
antiproliferative activity of the oil of S. parnassica has been studied. Our results show 
that the oil of S. parnassica is a weaker antiproliferative agent compared to that of S. 
thymbra against MCF-7 cells. From the EC50 values, S. thymbra oil possesses 40-fold 
times stronger activity than that of S. parnassica [EC50=0.002±0.00038% (v/v)] and 
EC50=0.08±0.03% (v/v), respectively]. The essential oils of S. thymbra has been 
studied again for its effect on MCF-7 cells together with C32 (human amelanotic 
melanoma cell line), ACHN (renal cell adenocarcinoma) and LNCaP (hormone-
dependent prostate carcinoma) cells (9). The oil derived from plants harvested in 
Lebanon was unable to affect the viability of MCF-7 and LNCaP cells. Nevertheless, 
it exhibited moderate cytotoxicity against C32 and ACHN cells.      
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 In our study, p-cymene and γ-terpinene were tested on MCF-7 cancer cells and 
did not appear to affect significantly their viability (EC50 > 4 mM). Conversely, carvacrol 
and thymol were approximately 15-25 times more potent than the other two agents. 
More specifically, thymol affected the viability of Hep3Β and A549 cells 
(EC50=0.181±0.016 mΜ and EC50=0.187±0.061 mΜ, respectively) to a greater extent 
compared with HepG2 cells, which were the most resistant not only to thymol 
(EC50=0.390±0.010 mΜ) but also to carvacrol (EC50=0.344±0.0035 mΜ). In the case 
of carvacrol, the most sensitive cell line was the lung adenocarcinoma A549 cell line 
(EC50=0.118±0.0012 mΜ), while Hep3B cells exhibited an intermediate effect 
(EC50=0.234±0.017 mΜ). In a study in 2003, carvacrol affected the viability of A549 
cells in concentrations greater than 0.250 mΜ when treated for 24 h (27). The activity 
of carvacrol against A549 cells was also described in another study, where it was 
considered a weakly cytotoxic agent (EC50>0.1 mΜ), not only against these cells but 
also against the DLD-1 colon adenocarcinoma  cell line (28). The sensitivity of HepG2 
cells to carvacrol was also determined in a study in 2011 (29). Cells were treated with 
different concentrations of carvacrol for 24, 48 and 72h. The EC50 value was lower 
after the 24 h treatment (0.4 mΜ) compared with that of the 48 and 72 h treatments 
(0.5 mΜ). This was verified in more recent work where HepG2 cells were treated with 
carvacrol for 24 h (30). Carvacrol has been tested against MDA-MB 231 (human 
metastatic breast cancer cells) (31), P-815 (murine mastocytoma), K-562  (human  
chronic  myelolytic  leukemia),  CEM (acute  T-lymphoblastoid  leukemia),  MCF-7  
(human breast  adenocarcinoma)  and  its  counterpart resistant  to gemcitabine  (MCF-
7  gem) (32, 33), human cervical cancer  HeLa  and  SiHa cells (34), CEM 
leiomyosarcoma cells (35), B16-F10 murine melanoma cells and rat brain N2a 
neuroblastoma cells (36), exhibiting moderate to strong antiproliferative activity.  
12 
 
 Of the cell lines we examined, thymol has only previously been tested again 
against HepG2 cells, where its EC50 value was estimated to be >0.1 mΜ (37). It has 
been studied for its activity against several cancer lines, including HL-60 acute 
promyelotic leukemia cells, B16-F10 cells and finally P-815, K-562, CEM and MCF-7 
cell lines. Thymol affected the viability of HL-60 cells after 24-h incubation, causing 
concentration-dependent apoptosis (38). B16-F10 melanoma cells exhibited the same 
sensitivity to thymol in two separate studies (39). This sensitivity was higher than a 
third study dealing with the same cell line (37),  perhaps due to different incubation 
times and cell viability assays. Finally, its effect on P-815, K-562, CEM and MCF-7 cell 
lines was diverse, with EC50 values ranging from 0.15-0.48 μΜ (33).  
 p-Cymene and γ-terpinene are the least studied substances among the four 
terpenes for their antiproliferative activity. They were both found to be weak anticancer 
agents against A549 and DLD-1 cells (EC50>0.1 μmΜ) (28). Their antiproliferative 
potential was also tested against K562 and murine B16-F10 cells, showing stronger 
activity against the B16-F10 cells, with γ-terpinene being more potent (37). The 
potential of p-cymene against B16-F10 cells has been examined before, but it did not 
have any significant anticancer activity (39). γ-Terpinene was tested against Jurkat (T-
leukemia cells), J774A.1 (murine macrophage tumor), and HeLa cells, where it 
showed weak cytotoxicity against Jurkat cells but had no effect on the other two cell 
lines (40).  
 Taking these data into consideration, the higher potency of S.thymbra 
compared to S.parnassica oil may be attributed to its composition (Table I). S. thymbra 
contains a higher percentage of carvacrol, which is a proven strong natural agent. In 
addition, p-cymene and γ-terpinene account for 25% of S. parnassica essential oil, 
whereas they comprise <20% in the oil of S. thymbra.   
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 In conclusion, these data suggest that the essential oils of S. thymbra and S. 
parnassica may have potential as health-promoting agents. Their major components, 
carvacrol and thymol, exhibited significant antioxidant capacity and also diverse 
antiproliferative activity against  A549 non-small  cell  lung  adenocarcinoma and 
HepG2  and  Hep3B liver  hepatocellular  carcinoma  cells, with the first two being the 
most sensitive to their action. p-Cymene and γ-terpinene did not exhibit equivalent 
antioxidant and antiproliferative potency. Some of these results are reported for the 
first time, while others are in agreement with previous studies, supporting the need for 
further investigation of the molecular mode of action of these substances in order to 
enable their future exploitation as potential effective nutraceutical compounds. 
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Table I. Content of the main components of the essential oils of the plants Satureja 
thymbra and S. parnassica harvested after their flowering season from Greek 
mountains [4].   
 
 
 
 
 
 
 
 
 
  
 
S. thymbra S. parnassica 
Component Content (%) 
Carvacrol  39.10 33.72 
Thymol  12.59 17.82 
p-Cymene  8.83 10.32 
γ-Terpinene  10.61 15.47 
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Table II. Antioxidant capacity of the terpenes γ-terpinene and p-cymene expressed as 
inhibition of the free radical 2,2-diphenyl-1-picrylhydrazyl. Data are given as the mean 
of at least three independent experiments ± standard deviation. 
 
Concentration 
(mM) 
 Inhibition (%) 
γ-Terpinene p-Cymene 
0.1 0.4 ± 0.007 0.7 ± 0.04 
0.2 0.4 ± 0.005 0.5 ± 0.075 
0.3 0.6 ± 0.014 0.5 ± 0.022 
0.6 0.3 ± 0.01 0.6 ± 0.007 
0.8 0.4 ± 0.0083 0.8 ± 0.023 
1 0.2 ± 0.0038 0.4 ± 0.002 
2 1.8 ± 0.015 1.6 ± 0.02 
3 1.2 ± 0.017 1 ± 0.031 
4 2.5 ± 0.022 1 ± 0.031 
6 3.4 ± 0.008 1.3 ± 0.009 
8 4.7 ± 0.014 1.8 ± 0.036 
10 3.6 ± 0.045 1.1 ± 0.03 
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Table III. ΕC50 (50% efficient concentration) values for the studied terpenes against 
different cancer cell lines. Data are given as the mean of at least three independent 
experiments ± standard deviation. 
 
EC50  values (mM) 
Cell line Carvacrol Thymol γ-Terpinene p-Cymene 
MCF-7 - - 4.6±0.11 5.11±0.55 
A549  0.118±0.0012 0.187±0.061 - - 
Hep3B  0.234±0.017 0.181±0.016 - - 
HepG2  0.344±0.0035 0.390±0.01 - - 
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Figure 1. Antioxidant capacity of the essential oils of Satureja thymbra and S. 
parnassica using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging method. 
Increasing concentrations of the essential oils of S. thymbra [0.01-2.5% (v/v)] and S. 
parnassica [0.05-2% (v/v)] were incubated in the presence of DPPH for 30 min. The 
results are shown as mean ± S.D. of three independent experiments. IC50 (50% 
inhibitory concentration) for  S. parnassica = 0.4±0.3% v/v, and IC50 for S. thymbra = 
0.22±0.25 % v/v. 
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Figure 2. DPPH-free radical scavenging activity of carvacrol and thymol. DPPH was 
incubated in the presence of increasing concentrations of carvacrol and thymol (1-10 
mM) for 30 min. The results are shown as the mean ± S.D. of three independent 
experiments. IC50 (50% inhibitory concentration) for thymol = 1.14±0.18 mM, and 
IC50 for carvacrol = 2.28±0.45 mM. 
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Figure 3. Antiproliferative activity of Satureja thymbra and S. parnassica essential oils. 
MCF-7 cells were incubated with increasing concentrations of S. thymbra and S. 
parnassica essential oils [0.00000025-0.25% (v/v)] for 72 h. Estimation of cell viability 
was determined by the SRB assay. The results are shown as the mean ± S.D. of three 
independent experiments. EC50 (50% efficient concentration) for S. parnassica = 
0.08±0.03% v/v, EC50 for S. thymbra = 0.002±0.0038% v/v. 
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Figure 4. Antiproliferative activity of carvacrol (A) and thymol  (B). Cells were 
incubated with increasing concentrations of carvacrol, and thymol (0.001-1mM) for 72 
h. Estimation of cell viability was determined by the sulforhodamine B assay. The 
results are shown as the mean ± S.D. of three independent experiments. 
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